Our facultative expertise has become RGA’s calling card within the industry and served as a springboard for our growth globally.

Read More

1. The intimate link between risk and capital
2. Optimisation means making trade-offs
...

Read More

Read More

Lung cancer is the most frequently diagnosed cancer worldwide. It continues to be the leading cause of cancer mortality in both men and women, accounting for 1.69 million deaths worldwide in 2015¹. 

This article reviews key advances in the manag...

Read More

Hypertrophic cardiomyopathy (HCM) is a heterogeneous inherited cardiac condition which has been studied intensely ever since the publication of its first formal description in 1958. Research in this field has benefited greatly from the development of echocardiography...

Read More

The rapid ageing of many of Asia’s nations is definitely a challenge, and is opening opportunities for insurers in the region as well. Mr. Georgio Mosis from RGAx Asia, examines innovative ways to meet the ageing populations’ fast-emerging health and wellness needs. Read More

It happens in all parts of life: The solution we seek is often much closer than we think it is. The same holds true for insurers seeking to increase policy sales. While it is logical to look to the uninsured and seek to expand into untapped populations for new business ... Read More

With a teen driver in my house, safe driving is top of mind. Read More

From the proliferation of digital health data comes a second challenge: that of keeping the data secure.

Read More

Find out what’s new, from hypertrophic Cardiomyopathy to lung cancer to blockchain in electronic health records.

Read More

n extremely high GI or MAX limit suggests a more aggressive or “heated” underwriting philosophy and greater risk tolerance. A more conservative GI/MAX level, on the other hand, can have a chilling effect, potentially rendering both a plan design – and its carrier – unco... Read More

To better understand fraud, RGA surveyed insurers and researched trends. The result? An analysis that spans definition, prevention, protection, and cost. Investigating Life Insurance Fraud and Abuse explores how insurers are addressing an old problem with new tools, ...

Read More

In just one year, almost  $3 billion were invested in insurtech — in de novo technology and in the brains driving it.  RGA's Farron Blanc delves into the causes and consequences of past, present and and pending technology revolutions.  Read More

The high costs of orphan drugs have made insuring people with rare diseases particularly challenging for health carriers. Janine Graham and Bonnie Schaumburg shared  insights on this topic and strategies for managing costs at the ROSE® Conference. Contact us&nbs...

Read More

Digitization has changed how we work and consume; blockchain promises to change how we trust. RGA urges insurers to consider the art of the possible in a useful primer. This article is based on research that won recognition at the International Insurance Society ...

Read More

For too long, e-underwriting technology has not advanced nearly as fast as the rate of new data made available. As we look ahead to the era of artificial intelligence, cognitive computing, and machine learning, RGA explores how a new solution from  Read More

Advances in bioelectronic technology – and the resulting influx of data – promise to reshape the underwriting process. Preparing today can help insurers capitalize on the opportunities of tomorrow. Contact us to learn more about wearables, wellness, digital...

Read More

RGA’s ROSE Program is the reinsurance industry’s premier medical and claim consulting program and is available to RGA clients.  Read More

This article discusses advances in fetal medicine and whether specialized fetal cover might help contain the often catastrophic costs of congenital claims for both parents and insurers.  Read More

RGA's Underwriting Specialties team offers industry-leading underwriting expertise in the trends, guidelines, risks, and ratings associated with ten unique case types, including for professional athletes.

Read More